KCNMA1 and pachyonychia congenita: In conclusion, the present results suggest that KCa1.1 may be a key modulator of antiandrogen resistance in androgen-sensitive, KCa1.1 gene-amplified PC, and that KCa1.1 inhibitors may overcome acquired antiandrogen resistance in PCSCs.